Rodrigo A. Fasce

Rodrigo A. Fasce

Auto-generated profile, based on publicly available information

Rodrigo A. Fasce

Subdepartment of Viral Diseases, Public Health Institute of Chile, Santiago, Chile

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
Saverio CainiSaverio Caini
Saverio Caini
PSPeter Spreeuwenberg
Peter Spreeuwenberg
GKGabriela F Kusznierz
Gabriela F Kusznierz
JRJuan Manuel Rudi
Juan Manuel Rudi
RORhonda Owen
Rhonda Owen
GGGlobal Influenza B Study group
Global Influenza B Study group
Influenza disease burden varies by age and this has important public health implications. We compared the proportional distribution of different influenza virus types within age strata using surveillance data from twenty-nine countries during 1999-2014 (N=358,796 influenza cases). For each virus, we calculated a Relative Illness Ratio (defined as the ratio of the percentage of cases in an age group to the percentage of the country population in the same age group) for young children (0-4 years), older children (5-17 years), young adults (18-39 years), older adults (40-64 years), and the elderly (65+ years). We used random-effects meta-analysis models to obtain summary relative illness ratios (sRIRs), and conducted meta-regression and sub-group analyses to explore causes of between-estimates heterogeneity. The influenza virus with highest sRIR was A(H1N1) for young children, B for older children, A(H1N1)pdm2009 for adults, and (A(H3N2) for the elderly. As expected, considering the diverse nature of the national surveillance datasets included in our analysis, between-estimates heterogeneity was high (I2>90%) for most sRIRs. The variations of countries’ geographic, demographic and economic characteristics and the proportion of outpatients among reported influenza cases explained only part of the heterogeneity, suggesting that multiple factors were at play. These results highlight the importance of presenting burden of disease estimates by age group and virus (sub)type.

13 June 2023 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
ACAndrés Castillo
Andrés Castillo
RFRodrigo Fasce
Rodrigo Fasce
BPBarbara Parra
Barbara Parra
WAWinston Andrade
Winston Andrade
PCPaulo Covarrubias
Paulo Covarrubias
JFJorge Fernández
Jorge Fernández
Avian influenza (AI), commonly named bird flu, is a type of Influenza virus that affects wild birds and poultry. The AI viruses can be present in a combination of 16 hemagglutinin (HA) and 9 neuraminidase (NA) subtypes. AI H5N1 cases were first described in Hong Kong in 1997 when birds died from an outbreak of the disease. 1 Later that year, a zoonotic transmission of H5N1 was reported in a 3-year-old child in Hong Kong, the first case of H5N1 disease in humans. At that time, the outbreak affected 18 patients with a case fatality rate of 33% for this virus subtype. 2, 3

28 October 2022 in MMWR. Morbidity and Mortality Weekly Report
Verified
Journal Article
Open access
MBMaría Fernanda Olivares Barraza
María Fernanda Olivares Barraza
RFRodrigo A Fasce
Rodrigo A Fasce
FNFrancisco Nogareda
Francisco Nogareda
PMPerrine Marcenac
Perrine Marcenac
NMNatalia Vergara Mallegas
Natalia Vergara Mallegas
EAEduardo Azziz-Baumgartner
Eduardo Azziz-Baumgartner
This report describes influenza incidence and vaccine effectiveness during the influenza season in the Southern Hemisphere.

2 December 2022 in American Journal of Transplantation
Verified
Journal Article
Open access
MBMaría Fernanda Olivares Barraza
María Fernanda Olivares Barraza
RFRodrigo A. Fasce
Rodrigo A. Fasce
FNFrancisco Nogareda
Francisco Nogareda
PMPerrine Marcenac
Perrine Marcenac
NMNatalia Vergara Mallegas
Natalia Vergara Mallegas
EAEduardo Azziz-Baumgartner
Eduardo Azziz-Baumgartner

1 July 2011 in Revista médica de Chile
Verified
Journal Article
Closed access
PDF file
RFRodrigo A Fasce
Rodrigo A Fasce
JTJavier Tognarelli
Javier Tognarelli
JMJudith Mora
Judith Mora
GTGraciela Torres
Graciela Torres
WAWinston Andrade
Winston Andrade
JFJorge Fernández
Jorge Fernández

1 September 2026 in Communications Health
Verified
Journal Article
Open access
PDF file
JLJingyi Liang
Jingyi Liang
RFRodrigo Fasce
Rodrigo Fasce
SLSaturnino Luz
Saturnino Luz
YLYou Li
You Li
HNHarish Nair
Harish Nair
Background: Higher temperatures and more frequent heat waves and cold spells due to climate change raise concerns for respiratory health. However, the association of extreme temperature events with RSV epidemics remains unclear. Method: We conducted time-series analyses to assess relative risks from exposure to extreme temperatures alone and joint exposure to extreme temperatures and high-level particulate matter [2.5 microns or less in diameter ( $${{{\rm{PM}}}}_{2.5}$$ PM 2.5 )] pollution on RSV circulating strength. Japan and Chile were selected as two contrasting settings with distinct climatic and geographic backgrounds. Weekly data on laboratory-confirmed RSV-positive cases, denominator population, meteorological factors, and air pollutants were collected from 16 Chilean regions (2015–2018) and 47 Japanese prefectures (2013–2019). We fitted quasi-Poisson regression to assess the local-level estimates and used random-effects meta-analyses to obtain national estimates. Results: Here we show that heat waves are linked to increased RSV circulating intensity in Japan, with relative risks up to 1.49 (95% confidence interval (CI): 1.29–1.73). Cold spells show weaker but positive effects. Although cold spells demonstrate no consistent effects in Chile, joint exposure to high-level $${{{\rm{PM}}}}_{2.5}$$ PM 2.5 pollution and cold spells increases risks by 32% (95% CI: 1.10–1.58). Joint exposure to high-level $${{{\rm{PM}}}}_{2.5}$$ PM 2.5 pollution and heat waves raises risk by up to 66% (95% CI: 1.27–2.16) in Japan. Conclusions: These findings reveal national patterns and regional variations in RSV responses to extreme temperatures, highlighting the need for public health measures targeting modifiable population-level factors amid global climate change.